Bayer Rises Following Trump Administration's Support for Supreme Court Review in Roundup Lawsuit

Written by Emily J. Thompson, Senior Investment Analyst

Source: SeekingAlpha

Updated: Dec 02 2025

0mins

Source: SeekingAlpha

Bayer's Stock Surge: Bayer's stock rose by 11.3% in European trading following support from the Trump administration for its appeal to the U.S. Supreme Court regarding lawsuits linked to its Roundup weedkiller.
Solicitor General's Recommendation: U.S. Solicitor General D. John Sauer recommended that the Supreme Court hear Bayer's challenge to a $1.25 million jury verdict, arguing that federal pesticide law should preempt state-level failure-to-warn claims.
EPA's Position on Glyphosate: Sauer highlighted that the U.S. Environmental Protection Agency has consistently found glyphosate, the active ingredient in Roundup, not likely to be carcinogenic, supporting Bayer's case.
Bayer's Litigation Strategy: Analysts noted that the Solicitor General's backing is a positive development for Bayer as it aims to resolve glyphosate-related litigation by the end of 2026 as part of its strategic plan.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.